Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate Cancer
- Sponsor
- Stanford University
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Micro-Ultrasound Detection of High Grade Prostate Cancer (Gleason Score ≥7) vs. Surgical Pathology
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
The goal of this study is to use a clinical micro-ultrasound to systematically image the prostate before biopsy or surgery. The images from the ultrasound system will be saved and compared to other imaging modalities and pathology in order to develop better tools.
Investigators
Geoffrey Sonn
Associate Professor of Urology
Stanford University
Eligibility Criteria
Inclusion Criteria
- •Scheduled for MR-US fusion prostate biopsy or radical prostatectomy
- •Agree to consent to the study
Exclusion Criteria
- •Does not agree to consent.
Outcomes
Primary Outcomes
Micro-Ultrasound Detection of High Grade Prostate Cancer (Gleason Score ≥7) vs. Surgical Pathology
Time Frame: From date of micro ultrasound exam until the date of Prostate biopsy data are obtained (average of 7 days)
Evaluate the ability of micro-ultrasound to identify high grade prostate cancer foci (Gleason score ≥7) in comparison to final surgical pathology result (prostatectomy or biopsy)
Secondary Outcomes
- Prostate Cancer Border Identification Post-Prostatectomy(3 years)
- Micro-Ultrasound Detection of Low Grade Prostate Cancer (Gleason Score 6)(1 year and 10 months)
- Prostate Cancer Detection: Micro-Ultrasound vs. mpMRI Comparison(1 year and 10 months)
- Measuring Correlation Between Prostatectomy Pathology and Imaging Correlation(3 years)